Traditional immunotherapy for metastatic melanoma is mainly divided into the following five categories: cytokines such as interleukin 2 (IL-2) and α interferon (IFN-α), tumor vaccine based on melanoma antigen or DC, oncolytic virus, T cell adoptive therapy and immune checkpoint inhibitors (ICIs). Here, IL2 is linked to melanoma.